EFTYX Trademark

Trademark Overview


On Monday, March 11, 2013, a trademark application was filed for EFTYX with the United States Patent and Trademark Office. The USPTO has given the EFTYX trademark a serial number of 79130219. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Monday, September 13, 2021. This trademark is owned by Novartis AG. The EFTYX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention or treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculo-skeletal system and the genitourinary system, for the treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases, for the treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; anti-fungal, anti-infective, antiviral and antibiotic preparations
eftyx

General Information


Serial Number79130219
Word MarkEFTYX
Filing DateMonday, March 11, 2013
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateMonday, September 13, 2021
Registration Number4412882
Registration DateTuesday, October 8, 2013
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, July 23, 2013

Trademark Statements


Goods and ServicesPharmaceutical preparations for the prevention or treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculo-skeletal system and the genitourinary system, for the treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases, for the treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; anti-fungal, anti-infective, antiviral and antibiotic preparations
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, February 26, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events


Event DateEvent Description
Monday, April 18, 2022NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Monday, April 18, 2022DEATH OF INTERNATIONAL REGISTRATION
Tuesday, October 26, 2021TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, February 26, 2021CANCELLED SECTION 71
Sunday, December 1, 2013NOTIFICATION PROCESSED BY IB
Friday, November 8, 2013FINAL DISPOSITION NOTICE SENT TO IB
Friday, November 8, 2013FINAL DISPOSITION PROCESSED
Thursday, November 7, 2013GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, October 8, 2013REGISTERED-PRINCIPAL REGISTER
Tuesday, July 23, 2013PUBLISHED FOR OPPOSITION
Wednesday, July 3, 2013NOTICE OF PUBLICATION
Sunday, June 16, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 11, 2013ASSIGNED TO EXAMINER
Tuesday, June 11, 2013APPLICATION FILING RECEIPT MAILED
Wednesday, June 5, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, June 4, 2013LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, May 30, 2013SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB